Total Payments
$14,977
2024 Payments
$3,206
Companies
26
Transactions
237
Medicare Patients
2,712
Medicare Billing
$205,532

Payment Breakdown by Category

Consulting$10,175 (67.9%)
Food & Beverage$4,703 (31.4%)
Education$99.00 (0.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $10,175 1 67.9%
Food and Beverage $4,703 235 31.4%
Education $99.00 1 0.7%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $10,482 8 $0 (2024)
ABBVIE INC. $739.48 48 $0 (2024)
LEO Pharma Inc. $492.08 24 $0 (2024)
Janssen Biotech, Inc. $398.54 22 $0 (2024)
SUN PHARMACEUTICAL INDUSTRIES INC. $378.08 14 $0 (2024)
GENZYME CORPORATION $363.54 17 $0 (2024)
PFIZER INC. $313.26 29 $0 (2024)
E.R. Squibb & Sons, L.L.C. $244.20 13 $0 (2024)
Lilly USA, LLC $205.84 13 $0 (2024)
Regeneron Healthcare Solutions, Inc. $160.30 5 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,206 165 ABBVIE INC. ($530.30)
2023 $1,275 68 AbbVie Inc. ($209.18)
2022 $10,175 1 Novartis Pharmaceuticals Corporation ($10,175)
2021 $99.00 1 Janssen Biotech, Inc. ($99.00)
2019 $97.33 1 Allergan Inc. ($97.33)
2018 $125.00 1 Genentech USA, Inc. ($125.00)

All Payment Transactions

237 individual payment records from CMS Open Payments — Page 2 of 10

Date Company Product Nature Form Amount Type
10/02/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $10.96 General
Category: IMMUNOLOGY
10/01/2024 PFIZER INC. EUCRISA (Drug), CIBINQO, LITFULO Food and Beverage In-kind items and services $13.63 General
Category: DERMATOLOGY
09/26/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $25.93 General
Category: DERMATOLOGY
09/26/2024 Ortho Dermatologics, a division of Bausch Health US, LLC Cabtreo (Drug) Food and Beverage In-kind items and services $24.38 General
Category: Dermatology
09/25/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $11.90 General
Category: Immunology
09/25/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $3.09 General
Category: Immunology
09/24/2024 Arcutis Biotherapeutics, Inc. Zoryve (Drug) Food and Beverage In-kind items and services $15.83 General
Category: Dermatology
09/20/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $29.70 General
Category: INFLAMMATION AND IMMUNOLOGY
09/19/2024 SUN PHARMACEUTICAL INDUSTRIES INC. ILUMYA (Biological) Food and Beverage In-kind items and services $17.57 General
Category: Dermatology
09/18/2024 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $23.07 General
Category: Inflammation
09/18/2024 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $3.91 General
Category: Inflammation
09/17/2024 LEO Pharma Inc. ADBRY (Biological) Food and Beverage In-kind items and services $29.53 General
Category: DERMATOLOGY
09/16/2024 Organogenesis Inc. AFFINITY (Medical Supply) Food and Beverage In-kind items and services $19.78 General
Category: WOUND CARE
09/10/2024 MAYNE PHARMA COMMERCIAL LLC Food and Beverage In-kind items and services $26.73 General
09/09/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $11.70 General
Category: Immunology
09/04/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $20.71 General
Category: FACIAL AESTHETICS
09/04/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $13.39 General
Category: IMMUNOLOGY
08/29/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $23.88 General
Category: DERMATOLOGY
08/28/2024 Biofrontera Inc. AMELUZ (Drug), BF-RhodoLED, XEPI Food and Beverage Cash or cash equivalent $15.03 General
Category: DERMATOLOGY
08/27/2024 Organon Llc HADLIMA (Drug) Food and Beverage In-kind items and services $31.83 General
Category: ADALIMUMAB-BWWD
08/26/2024 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $19.58 General
08/22/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $12.92 General
Category: Immunology
08/21/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $22.79 General
Category: Immunology
08/20/2024 Novartis Pharmaceuticals Corporation COSENTYX (Drug) Food and Beverage In-kind items and services $93.16 General
Category: Dermatology
08/20/2024 Krystal Biotech Inc VYJUVEK (Drug) Food and Beverage In-kind items and services $15.28 General
Category: DERMATOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 496 769 $55,927 $35,136
2022 13 881 1,431 $256,923 $68,123
2021 13 713 1,168 $211,821 $61,593
2020 13 622 858 $164,410 $40,679
Total Patients
2,712
Total Services
4,226
Medicare Billing
$205,532
Procedure Codes
49

All Medicare Procedures & Services

49 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
11102 Biopsy of related skin growth, first growth Office 2023 90 101 $10,409 $6,473 62.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 72 84 $7,617 $5,185 68.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 43 43 $7,052 $4,826 68.4%
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm Office 2023 17 19 $5,533 $4,338 78.4%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 54 54 $5,805 $3,533 60.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 40 45 $5,997 $3,398 56.7%
17000 Destruction of precancer skin growth, 1 growth Office 2023 73 83 $5,590 $2,394 42.8%
17110 Destruction of skin growth, 1-14 growths Office 2023 26 31 $3,361 $2,101 62.5%
11103 Biopsy of related skin growth, each additional growth Office 2023 26 50 $2,721 $1,849 67.9%
17003 Destruction of precancer skin growth, 2-14 growths Office 2023 55 259 $1,842 $1,040 56.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 192 293 $81,576 $25,894 31.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 164 191 $37,436 $11,216 30.0%
11102 Biopsy of related skin growth, first growth Office 2022 117 132 $39,732 $8,514 21.4%
17110 Destruction of skin growth, 1-14 growths Office 2022 84 98 $32,242 $7,625 23.6%
17000 Destruction of precancer skin growth, 1 growth Office 2022 103 117 $22,464 $3,795 16.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 23 23 $9,395 $2,673 28.5%
11104 Punch biopsy, first skin growth Office 2022 24 24 $9,048 $2,304 25.5%
17003 Destruction of precancer skin growth, 2-14 growths Office 2022 85 379 $7,201 $1,902 26.4%
11103 Biopsy of related skin growth, each additional growth Office 2022 26 45 $6,885 $1,760 25.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 18 18 $4,716 $947.89 20.1%
11900 Injection into skin growth, 1-7 growths Office 2022 14 26 $4,264 $827.95 19.4%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 14 14 $1,680 $603.50 35.9%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2022 17 71 $284.00 $58.66 20.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 107 192 $51,812 $18,268 35.3%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 131 160 $30,087 $10,359 34.4%

About Dr. Priyanka Vedak, M.D

Dr. Priyanka Vedak, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Chapel Hill, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2015. The National Provider Identifier (NPI) number assigned to this provider is 1316327000.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Priyanka Vedak, M.D has received a total of $14,977 in payments from pharmaceutical and medical device companies, with $3,206 received in 2024. These payments were reported across 237 transactions from 26 companies. The most common payment nature is "Consulting Fee" ($10,175).

As a Medicare-enrolled provider, Vedak has provided services to 2,712 Medicare beneficiaries, totaling 4,226 services with total Medicare billing of $205,532. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.

Practice Information

Products in Payments

  • COSENTYX (Biological) $10,175
  • DUPIXENT (Biological) $523.84
  • ADBRY (Biological) $492.08
  • TREMFYA (Drug) $398.54
  • ILUMYA (Biological) $318.28
  • COSENTYX (Drug) $307.35
  • RINVOQ (Biological) $277.66
  • SKYRIZI (Biological) $271.23
  • EUCRISA (Drug) $264.26
  • Sotyktu (Drug) $244.20
  • TALTZ (Drug) $205.84
  • BOTOX (Biological) $190.59
  • Otezla (Drug) $157.85
  • Erivedge (Biological) $125.00
  • Bimzelx (Biological) $124.81
  • Cabtreo (Drug) $106.43
  • VTAMA (Drug) $85.56
  • Zoryve (Drug) $60.58
  • Winlevi (Drug) $59.80
  • HADLIMA (Drug) $54.02

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Chapel Hill